645 Ventures — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Upside provides end-to-end housing stabilization services for individuals experiencing housing instability within healthcare settings, serving health plans, employers, and their members across Medicaid, Medicare, and employer coverage.
Enterprise SoftwareHealthtechSaaSSocialWellness & FitnessFort Lauderdale, US
Jake(CEO)inPeter Badgley(Executive Officer, Director)inJacob Rothstein(Executive Officer, Director)
Board seatAaron Holiday· per SEC Form D
Co-investorsEquitage Ventures, L.L.C.Flare Capital PartnersTechstars
ECL provides non-dilutive, revenue-based financing to SaaS and AI companies with recurring revenue, using AI-assisted underwriting to make cross-border funding decisions quickly.
AI & Machine LearningFintechSaaSNew York, US
KAUSTAV DAS(Executive Officer, Director)inMANISH ARORA(Director)in
BoardSANDEEP PATIL(Director)in
Board seatAaron Holiday· per SEC Form D
Co-investorsEudemian VenturesEverywhere VenturesLorimer VenturesQED InvestorsTwo Culture CapitalThe Fund
New York, US
Board seatNnamdi Okike· per SEC Form D · $7M raise · filed May 2024
Austin, US
Benjamin Rubenstein(Executive Officer, Director)Stuart Wall(Executive Officer, Director)Michael Lam(Executive Officer, Director)Michael Dixon(Executive Officer)Danielle DePalma(Executive Officer)
BoardDavid Haber(Director)in
Board seatNnamdi Okike· per SEC Form D · $30M raise · filed Mar 2024
Co-investorsAndreessen Horowitz
Squire operates a two-sided platform where customers can book appointments with barbers while shop owners gain access to integrated booking, payment processing, inventory, and payroll tools to manage their operations.
ConsumerNew York City, US
Songe LaRon(Founder/CEO)inDave Salvant(Founder/President)in
PartnerAaron Holiday· led
Co-investorsAltaIR CapitalAurumCRV (Charles River Ventures)Debut CapitalICONIQMaccabee Ventures+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.